Morgan Stanley Liquidia Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Liquidia Corp stock. As of the latest transaction made, Morgan Stanley holds 334,845 shares of LQDA stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

334,845

Previous 533,364 37.22%

Holding current value

$3.89 Million

Previous $6.4 Million 47.69%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.9 - $14.11 $1.77 Million - $2.8 Million	-198,519 Reduced 37.22%	334,845 $3.35 Million
Q2 2024 Oct 17, 2024	SELL	$11.96 - $15.71 $1.82 Million - $2.39 Million	-152,075 Reduced 22.19%	533,364 $6.4 Million
Q2 2024 Aug 14, 2024	SELL	$11.96 - $15.71 $1.82 Million - $2.39 Million	-152,075 Reduced 22.19%	533,364 $6.4 Million
Q1 2024 Oct 17, 2024	BUY	$11.35 - $16.73 $1.73 Million - $2.54 Million	152,075 Added 28.51%	685,439 $10.1 Million
Q1 2024 Aug 16, 2024	SELL	$11.35 - $16.73 $3.64 Million - $5.37 Million	-320,918 Reduced 31.89%	685,439 $10.1 Million
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $3.64 Million - $5.37 Million	-320,918 Reduced 31.89%	685,439 $10.1 Million
Q4 2023 Aug 16, 2024	BUY	$5.77 - $12.19 $2.73 Million - $5.77 Million	472,993 Added 88.68%	1,006,357 $12.1 Million
Q4 2023 Feb 13, 2024	BUY	$5.77 - $12.19 $3.76 Million - $7.95 Million	652,384 Added 184.3%	1,006,357 $12.1 Million
Q3 2023 Nov 15, 2023	SELL	$6.27 - $8.15 $205,273 - $266,822	-32,739 Reduced 8.47%	353,973 $2.24 Million
Q2 2023 Aug 14, 2023	BUY	$6.63 - $9.9 $1.62 Million - $2.41 Million	243,864 Added 170.72%	386,712 $3.04 Million
Q1 2023 May 15, 2023	SELL	$5.72 - $7.91 $694,270 - $960,084	-121,376 Reduced 45.94%	142,848 $987,000
Q4 2022 Feb 14, 2023	SELL	$4.68 - $6.54 $333,099 - $465,484	-71,175 Reduced 21.22%	264,224 $1.68 Million
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $254,430 - $572,298	-68,212 Reduced 16.9%	335,399 $1.82 Million
Q2 2022 Oct 27, 2022	SELL	$3.37 - $7.55 $504,310 - $1.13 Million	-149,647 Reduced 27.05%	403,611 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $504,310 - $1.13 Million	-149,647 Reduced 27.05%	403,611 $1.76 Million
Q1 2022 Oct 27, 2022	BUY	$5.14 - $7.38 $769,185 - $1.1 Million	149,647 Added 37.08%	553,258 $3.97 Million
Q1 2022 May 13, 2022	BUY	$5.14 - $7.38 $671,371 - $963,953	130,617 Added 30.9%	553,258 $3.97 Million
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $447,372 - $853,473	165,082 Added 64.09%	422,641 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$2.28 - $2.95 $587,234 - $759,799	257,559 New	257,559 $710,000

Others Institutions Holding LQDA

# of Institutions

171

Shares Held

44.3M

Call Options Held

1.55M

Put Options Held

1.52M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $748M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account